EndoTAG-1 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Measurable Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas Failed on FOLFIRINOX Treatment

Press/Media: Press / Media

Period2018 Oct 2

Media coverage

1

Media coverage

  • TitleEndoTAG-1 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Measurable Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas Failed on FOLFIRINOX Treatment
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date18/10/2
    PersonsHee Seung Lee